Cargando…

Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common form of dementia, with cognitive impairment as a core symptom. Neuropsychiatric symptoms (NPSs) also occur as non-cognitive symptoms during the disease course, worsening the prognosis. Recent treatment guidelines for NPSs have recommended non-pharmacologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagata, Tomoyuki, Shinagawa, Shunichiro, Inamura, Keisuke, Shigeta, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501542/ https://www.ncbi.nlm.nih.gov/pubmed/36143150 http://dx.doi.org/10.3390/jpm12091365

Ejemplares similares

A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom
por: Nagata, Tomoyuki, et al.
Publicado: (2021)

Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients
por: Kobayashi, Nobuyuki, et al.
Publicado: (2022)

Blood DNA Methylation Levels in the WNT5A Gene Promoter Region: A Potential Biomarker for Agitation in Subjects with Dementia
por: Kobayashi, Nobuyuki, et al.
Publicado: (2021)

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
por: Kobayashi, Nobuyuki, et al.
Publicado: (2020)

Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia
por: Liew, Tau Ming
Publicado: (2020)

Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2013)

Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients
por: Nagata, Tomoyuki, et al.
Publicado: (2013)

Longitudinal Changes in the Government-Certified Index Stage and Requisite Costs for Long-Term Care Insurance System among the Community-Dwelling Demented Elderly in Japan
por: Shinagawa, Shunichiro, et al.
Publicado: (2013)

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization
por: Mar, Javier, et al.
Publicado: (2019)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden
por: Iravani, Behnam, et al.
Publicado: (2022)

Network Analysis of Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Goodwin, Grace J., et al.
Publicado: (2023)

Network analysis of neuropsychiatric symptoms in Alzheimer’s disease
por: Goodwin, Grace J., et al.
Publicado: (2023)

Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023)

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
por: Lanctôt, Krista L., et al.
Publicado: (2017)

Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis
por: Watt, Jennifer A., et al.
Publicado: (2020)

Neuropsychiatric Symptoms in Posterior Cortical Atrophy and Alzheimer Disease
por: Suárez-González, Aida, et al.
Publicado: (2016)

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
por: Ng, Kok Pin, et al.
Publicado: (2017)

Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
por: Schaffer Aguzzoli, Cristiano, et al.
Publicado: (2023)

Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
por: Corrigan, Rachel R., et al.
Publicado: (2022)

Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis protocol
por: Huang, Yu-Yuan, et al.
Publicado: (2020)

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment
por: Pless, Andrew, et al.
Publicado: (2023)

Attenuation of neuropsychiatric symptoms and caregiver burden in Alzheimer's disease by motor intervention: a controlled trial
por: Stella, Florindo, et al.
Publicado: (2011)

Post-Stroke Neuropsychiatric Complications: Types, Pathogenesis, and Therapeutic Intervention
por: Zhou, Jing, et al.
Publicado: (2023)

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2015)

Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer’s disease
por: Allegri, Ricardo F, et al.
Publicado: (2006)

Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer’s disease
por: Hall, James R, et al.
Publicado: (2015)

Neuropsychiatric symptoms of the elderly with Alzheimer's disease and the family caregivers' distress
por: Storti, Luana Baldin, et al.
Publicado: (2016)

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
por: Benhabib, Hadas, et al.
Publicado: (2013)

Neuropsychiatric symptoms as the main determinant of caregiver burden in Alzheimer’s disease
por: Kochhann, Renata, et al.
Publicado: (2011)

Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer's Disease
por: Hwang, Inha, et al.
Publicado: (2017)

Neuropsychiatric symptoms associated multimodal brain networks in Alzheimer's disease
por: Li, Kaicheng, et al.
Publicado: (2022)

Association of caregiver demographic variables with neuropsychiatric symptoms in Alzheimer’s disease patients for distress on the Neuropsychiatric Inventory (NPI)
por: Godinho, Cláudia, et al.
Publicado: (2008)

Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review
por: Seitz, Dallas P., et al.
Publicado: (2013)

The Economic Impact of New Therapeutic Interventions on Neuropsychiatric Inventory (NPI) Symptom Scores in Patients with Alzheimer Disease
por: Tafazzoli, Ali, et al.
Publicado: (2018)

Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease
por: Cummings, J, et al.
Publicado: (2015)

Hearing Loss and Neuropsychiatric Symptoms in Persons With Dementia at the End of Life
por: Nieman, Carrie, et al.
Publicado: (2021)

Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer’s disease
por: Ng, Kok Pin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5qbt07l717nga4a954gfob6sk